Evidence map›Paper›PMID 32222461›Full record

ArticleHuman pathology2020

Regenerative hepatic pseudotumor: a new pseudotumor of the liver.

Michael Torbenson, Saba Yasir, Robert Anders, Cynthia D Guy, Hee Eun Lee, Sudhakar K Venkatesh, Tsung-Teh Wu, Zongming Eric Chen

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Human pathology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Hepatic pseudotumor: A diagnostic challenge.World journal of hepatology · 2024
    Article
  4. Hepatic pseudotumor associated withWorld journal of hepatology · 2023
    Article
  5. Uncommon Benign Neoplasms and Pseudotumors of the Liver.Archives of pathology & laboratory medicine · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Michael TorbensonDepartment of Laboratory Medicine and Pathology, Mayo Clinic Rochester, USA, 55905. Electronic address: Torbenson.Michael@mayo.edu.
Saba YasirDepartment of Laboratory Medicine and Pathology, Mayo Clinic Rochester, USA, 55905.
Robert AndersDepartment of Pathology, Johns Hopkins University School of Medicine, USA, 21287.
Cynthia D GuyDepartment of Pathology, Duke University Health System, USA, 27710.
Hee Eun LeeDepartment of Laboratory Medicine and Pathology, Mayo Clinic Rochester, USA, 55905.
Sudhakar K VenkateshDepartment of Radiology, Mayo Clinic Rochester, USA, 55905.
Tsung-Teh WuDepartment of Laboratory Medicine and Pathology, Mayo Clinic Rochester, USA, 55905.
Zongming Eric ChenDepartment of Laboratory Medicine and Pathology, Mayo Clinic Rochester, USA, 55905.
Mayo Clinic · USDuke University Health System · USJohns Hopkins University · US

Funding

Tumor Antigens for Individual Signatures and TherapyP50CA062924 · NCI · JOHNS HOPKINS UNIVERSITY · PI JAFFEE, ELIZABETH M. · 1993 to 2022
$54.6M
Project 4: ImmunovirotherapyP50CA210964 · NCI · MAYO CLINIC ROCHESTER · PI Rory Smoot · 2018 to 2026
$20.5M
NCI NIH HHS P50 CA062924NCI NIH HHS P50 CA210964
6 · The paper itself

Abstract

Cases of new pseudotumors of the liver were collected from multiple medical centers. Four resection and 4 biopsy specimens were collected, including 4 women and 4 men at an average age of 48 ± 15 years (range: 28-73 years). The lesions were visible on imaging but were either ill-defined or had indeterminate features for characterization. They ranged in size from 2 to 9 cm and were multiple in five cases. The resection specimens showed lesions that had vague borders but were visible in juxtaposition to the normal liver on gross examination. Histologically, the lesions also had ill-defined borders and were composed of benign reactive liver parenchyma. Central vein thrombi were seen in 5 cases, and portal vein thrombi, in 2 cases. These vascular changes were associated reactive parenchymal changes including sinusoidal dilation, patchy bile ductular proliferation, and portal vein abnormalities. All lesions lacked the histological findings of hepatic adenomas, focal nodular hyperplasia, or other known tumors and pseudotumors of the liver. In summary, this study provides a detailed description of a new pseudotumor of the liver: a reactive, hyperplastic mass-like lesion that forms in association with localized vascular thrombi, for which we propose the term regenerative hepatic pseudotumor. This lesion can closely mimic other benign or malignant hepatic tumors on imaging and histology.

Indexed as

Cell ProliferationAdultAgedBiopsyFemaleGranuloma, Plasma CellHepatectomyHumansLiverLiver DiseasesMaleMiddle AgedPortal VeinUnited StatesVenous ThrombosisHepaticHyperplasiaLiverPseudotumorRegenerationThrombus

Identifiers

PMID32222461
PMCPMC9469469
OpenAlexW3013412419

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.